Gastrointestinal stromal tumors, version 2.2014 Journal Article

  


Authors: von Mehren, M.; Randall, R. L.; Benjamin, R. S.; Boles, S.; Bui, M. M.; Casper, E. S.; Conrad, E. U. 3rd; DeLaney, T. F.; Ganjoo, K. N.; George, S.; Gonzalez, R. J.; Heslin, M. J.; Kane, J. M. 3rd; Mayerson, J.; McGarry, S. V.; Meyer, C.; O'Donnell, R. J.; Pappo, A. S.; Paz, I. B.; Pfeifer, J. D.; Riedel, R. F.; Schuetze, S.; Schupak, K. D.; Schwartz, H. S.; Van Tine, B. A.; Wayne, J. D.; Bergman, M. A.; Sundar, H.
Article Title: Gastrointestinal stromal tumors, version 2.2014
Abstract: Gastrointestinal stromal tumors (GIST) are the most common soft tissue sarcoma of the gastrointestinal tract, resulting most commonly from KIT or platelet-derived growth factor receptor α (PDGFRα)-activating mutations. These NCCN Guideline Insights high-light the important updates to the NCCN Guidelines for Soft Tissue Sarcoma specific to the management of patients with GIST experiencing disease progression while on imatinib and/or sunitinib. © JNCCN-Journal of the National Comprehensive Cancer Network.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 12
Issue: 6
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2014-06-01
Start Page: 853
End Page: 862
Language: English
PROVIDER: scopus
PUBMED: 24925196
DOI: 10.6004/jnccn.2014.0080
DOI/URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-84902515659&partnerID=40&md5=b432bc2f8da7b79d5a8e7815f742ef44
Notes: JNCCN J. Nat. Compr. Cancer Netw. -- Export Date: 8 July 2014 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Karen D Schupak
    72 Schupak
  2. Ephraim S Casper
    108 Casper
Related MSK Work